N-of-One to Provide Interpretation Services for OncoDNA NGS Tests | GenomeWeb

NEW YORK (GenomeWeb) – N-of-One today said that it will provide OncoDNA with clinical interpretation services for its next-generation sequencing and other molecular tests for patients throughout Europe.

Belgium-based OncoDNA provides personalized medicine testing services for cancer patients. One of its tools is the OncoDEEP Clinical Plus test, which is an adapted version of the 400-gene Ion comprehensive cancer panel on the Ion Proton. It also offers a more focused targeted sequencing test, OncoDEEP Dx, using the 48-gene Ion AmpliSeq cancer panel.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.